Print

3M Drug Delivery Systems Signs Licensing Agreement with Spirig Pharma Ltd.  
12/16/2010 9:27:51 AM

ST. PAUL, Minn.--(BUSINESS WIRE)--3M Drug Delivery Systems has signed an exclusive licensing agreement with Spirig Pharma AG, a Swiss manufacturer of dermatological and dermocosmetic products. Spirig Pharma AG will utilize one of 3M’s immune response modifier (IRM) molecules to further its development of treatment for sun damaged skin. Spirig is known internationally for brands like its Daylong actinica®, a medical device for the prevention of certain forms of non-melanoma skin cancer in at risk patients, and Excipial moisturizer.
//-->